NCT07702019

Brief Summary

The goal of this observational study is to evaluate salivary biomarkers and perceived stress in adults with bruxism compared with healthy individuals. The study aims to determine whether salivary cortisol, immunoglobulin A (IgA), free kappa light chain (FLC-κ), free lambda light chain (FLC-λ), total free light chains, and perceived stress levels differ between individuals with bruxism and healthy controls. The main questions it aims to answer are:

  • Do salivary cortisol, IgA, FLC-κ, FLC-λ, and total free light chain levels differ between individuals with bruxism and healthy controls?
  • Is perceived stress associated with changes in salivary biomarkers in individuals with bruxism? Researchers will compare participants with bruxism and healthy control participants to evaluate differences in salivary biomarker levels and perceived stress. Participants will:
  • undergo a clinical examination for the diagnosis of bruxism or confirmation of healthy status;
  • complete the Perceived Stress Scale (PSS-14) questionnaire;
  • provide an unstimulated saliva sample for laboratory analysis of cortisol, IgA, free kappa light chain, free lambda light chain, and total free light chains.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

12 months

First QC Date

July 9, 2026

Last Update Submit

July 9, 2026

Conditions

Keywords

salivary biomarkersbruxismcortisolimmunoglobulin Afree light chainperceived stress

Outcome Measures

Primary Outcomes (1)

  • Perceived stress score (PSS-14 score)

    Comparison of PSS-14 scores between individuals with bruxism and non-bruxism controls.

    Baseline

Secondary Outcomes (1)

  • Salivary biomarker levels (cortisol, IgA, FLC-κ, FLC-λ, and total FLC)

    Baseline

Study Arms (2)

Bruxism

Adults diagnosed with bruxism based on clinical diagnostic criteria.

Healthy Controls

Age- and sex-matched healthy adults without signs or symptoms of bruxism.

Eligibility Criteria

Age25 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consisted of adults with clinically diagnosed bruxism and age- and sex-matched healthy control participants recruited from the Faculty of Dentistry. All participants underwent clinical examination, completed the Perceived Stress Scale (PSS-14), and provided unstimulated saliva samples for biomarker analysis.

You may qualify if:

  • Adults aged 25 to 50 years.
  • Systemically healthy individuals.
  • Presence of no more than four-unit fixed partial dentures.
  • Absence of clinical signs of oral inflammation.
  • Good oral hygiene.
  • Individuals diagnosed with bruxism according to the study diagnostic criteria (bruxism group) or healthy volunteers without signs or symptoms of bruxism (control group).
  • Ability and willingness to provide written informed consent.

You may not qualify if:

  • Use of medications that may affect the nervous system or salivary gland function (e.g., benzodiazepines, antidepressants).
  • Psychiatric disorders.
  • Epilepsy.
  • Diabetes mellitus or other pancreatic diseases.
  • Current corticosteroid therapy.
  • Cushing syndrome or Addison disease.
  • Pregnancy.
  • Current smoking.
  • Alcohol or substance abuse.
  • History of facial trauma.
  • Rheumatic muscle or joint disorders.
  • Degenerative joint disease.
  • Migraine.
  • Use of medications affecting sleep or motor activity.
  • Recent history of occlusal splint therapy.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Giresun University Faculty of Dentistry

Giresun, 28200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Bruxism

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesHabitsBehavior

Study Officials

  • Tugce Cevik Sonmez, DDS

    Giresun University Faculty of Dentistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 9, 2026

First Posted

July 14, 2026

Study Start

May 4, 2025

Primary Completion

April 30, 2026

Study Completion

June 15, 2026

Last Updated

July 14, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations